Author:
Wang Fu-Jun,Song Huai-Lei,Wang Xiao-Meng,Zhang Wen-Ji,Wang Bi-Lian,Zhao Jian,Hu Zhi-Bi
Publisher
Springer Science and Business Media LLC
Subject
Molecular Biology,Applied Microbiology and Biotechnology,Biochemistry,General Medicine,Bioengineering,Biotechnology
Reference6 articles.
1. Nag, B., Medicherla, S., Sharma, S.D. (2005). Orally active fraction of Momordica charantia, active peptides thereof, and their use in the treatment of diabetes. US Patent 6,852,695.
2. Hou, L. F., Zhao, Z. H., Li, B. C., Cai, Y. F., & Zhang, S. Q. (2009). TrxA mediating fusion expression of antimicrobial peptide CM4 from multiple joined genes in Escherichia coli. Protein Expression and Purification, 64, 225–230.
3. Rao, X. C., Hu, J. C., Li, S., Jin, X. L., Zhang, C., Cong, Y. G., Hu, X. M., Tan, Y. L., Huang, J. J., Chen, Z. J., Zhu, J. M., & Hu, F. Q. (2005). Design and expression of peptide antibiotic hPAB-β as tandem multimers in Escherichia coli. Peptides, 26, 721–729.
4. Liu, S. X., Fu, Z. P., Mu, R. M., Hu, Z. B., Wang, F. J., & Wang, X. R. (2010). Expression and characterization of Momordica charantia anti-hyperglycaemic peptide in Escherichia coli. Molecular Biology Reports, 37, 1781–1786.
5. Ségalas, I., Thai, R., Ménez, R., & Vita, C. (1995). A particularly labile Asp-Pro bond in the green mamba muscarinic toxin MTX2. Effect of protein conformation on the rate of cleavage. FEBS Letters, 371, 171–175.
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献